Rigel Pharmaceuticals, Inc.RIGLNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR+6.8%
5Y CAGR-13.6%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+6.8%/yr
vs -28.6%/yr prior
5Y CAGR
-13.6%/yr
Recent acceleration
Acceleration
+35.4pp
Accelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 2.62 | +58.7% |
| 2024 | 1.65 | -23.6% |
| 2023 | 2.16 | +0.4% |
| 2022 | 2.15 | -29.0% |
| 2021 | 3.03 | -44.3% |
| 2020 | 5.44 | -9.9% |
| 2019 | 6.04 | -27.2% |
| 2018 | 8.30 | -92.4% |
| 2017 | 109.30 | +891.8% |
| 2016 | 11.02 | - |